PLASMA-CONCENTRATION, URINARY-EXCRETION AND RENAL CLEARANCE OF L-CARNITINE DURING PREGNANCY - A REVERSIBLE SECONDARY L-CARNITINE DEFICIENCY

被引:21
作者
MARZO, A
CARDACE, G
CORBELLETTA, C
PACE, S
DIDDIO, S
VERROTTI, C
CAVATORTA, E
GRIGNAFFINI, A
机构
[1] Drug Metabolism and Pharmacokinetic Department, Parma
[2] Clinical Research Division, Cardiovascular Department, Pomezia, Rome, Parma, Sigma-Tau S.p.A.
[3] Clinica Ostetrica e Ginecologica Università di Parma, Parma
关键词
L-CARNITINE; PREGNANCY; PLASMA CONCENTRATION; RENAL CLEARANCE; SECONDARY L-CARNITINE DEFICIENCY;
D O I
10.3109/09513599409058032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma concentration, urinary excretion and renal clearance of free, total and esterified L-carnitine were monitored monthly in 14 women during the last 6 months of pregnancy and 1 month after delivery. Plasma concentration and renal clearance measured 1 month after delivery overlapped with normal values for females of comparable age, and were considered the reference values for further comparisons. Plasma concentration of free, total and esterified L-carnitine decreased during pregnancy, reaching values as low as half of those measured 1 month after delivery, whereas urinary excretion and renal clearance, mainly of L-carnitine esters, increased, with renal clearance reaching apeak at the 16th week of pregnancy. Pregnancy thus leads to a reversible secondary deficiency of L-carnitine. The involvement of L-carnitine in the excretion of an excess of acyl-S-coenzyme A groups to prevent a possible systemic acidosis, as well as hormonal changes and a reduction of L-carnitine biosynthesis, could play a significant role in the variations in L-carnitine metabolism encountered in pregnancy. As physiological components of L-carnitine are excreted via a saturable tubular reabsorption, their threshold seems to follow plasma concentration, even when they decrease markedly, as in pregnancy.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 13 条
[1]  
Engel A.G., Angelmi C., Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome, Science, 179, pp. 899-902, (1973)
[2]  
Breningstall G.N., Carnitine deficiency syndromes, Pediatr. Neurol., 6, pp. 75-81, (1990)
[3]  
Lysiak W., Lilly K., Di Lisa F., Toth P., Bieber L.L., Quantitation of the effect of L-carnitine on the level of acid soluble short-chain acyl-CoA and CoASH in rat heart. J, Biol. Chem., 263, pp. 1151-1156, (1988)
[4]  
Duran M., Loof N.E., Kettmg D., Dorland L., Secondary carnitine deficiency. J, Clin. Chem. Clin. Biochem., 28, pp. 359-363, (1990)
[5]  
Scholte H.R., Stinis J.T., Jennekens F.G.I., Low carnitine levels in serum of pregnant women. N, Engl. J. Med., 299, pp. 1079-1080, (1979)
[6]  
Novak M., Monkus E.F., Chung D., Buch M., Carnitine in the perinatal metabolism of lipids I. Relationship between maternal and fetal plasma levels of carnitines and acyl carnitines, Pediatrics, 67, pp. 95-100, (1981)
[7]  
Cederblad G., Niklasson A., Rydgren B., Wirklend K.A., Olegard R., Carnitine in the maternal and neonatal plasma, Acta Paediatr. Scand., 74, pp. 500-504, (1985)
[8]  
Cederblad G., Fahraeus L., Lindgren K., Plasma carnitine and renal-carnitine clearance during pregnancy, Am. J. Clin. Nutr., 44, pp. 379-383, (1986)
[9]  
McGarry J.D., Foster D.W., Bergmeyer J., Grabl M., Free and esterified carnitine: radio method, Methods of Enzymatic Analysis, 3rd edn., VIII, pp. 474-481, (1983)
[10]  
Marzo A., Cardace G., Arngoni Martelli E., Enzymes in stereoselective pharmacokinetics of endogenous substances, Chirality, 4, pp. 247-251, (1992)